Rübsamen-Waigmann H - Search Results

1

Production and testing of a proposed reference preparation of the purified main allergen from castor beans.

Rübsamen-Waigmann H, Winkler KO, Müller HW, Kaiser PE, Spener F, Rickers Y, Brede HD. Rübsamen-Waigmann H, et al. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1987;(80):95-106. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1987. PMID: 3688878 No abstract available.

2

[HIV-2 infection also in Germany].

Doerr HW, Selb B, Brede HD, Biesert L, von Briesen H, Rübsamen-Waigmann H. Doerr HW, et al. Dtsch Med Wochenschr. 1987 Jul 31;112(31-32):1237. Dtsch Med Wochenschr. 1987. PMID: 3608849 German. No abstract available.

3

Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning.

von Briesen H, Becker WB, Henco K, Helm EB, Gelderblom HR, Brede HD, Rübsamen-Waigmann H. von Briesen H, et al. J Med Virol. 1987 Sep;23(1):51-66. doi: 10.1002/jmv.1890230107. J Med Virol. 1987. PMID: 2890703

4

Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS.

Rübsamen-Waigmann H, Becker WB, Helm EB, Brodt R, Fischer H, Henco K, Brede HD. Rübsamen-Waigmann H, et al. J Med Virol. 1986 Aug;19(4):335-44. doi: 10.1002/jmv.1890190406. J Med Virol. 1986. PMID: 2427649

5

HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype.

Pfützner A, Dietrich U, von Eichel U, von Briesen H, Brede HD, Maniar JK, Rübsamen-Waigmann H. Pfützner A, et al. J Acquir Immune Defic Syndr (1988). 1992 Oct;5(10):972-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1453326

6

High proportion of HIV-2 and HIV-1/2 double-reactive sera in two Indian states, Maharashtra and Goa: first appearance of an HIV-2 epidemic along with an HIV-1 epidemic outside of Africa.

Rübsamen-Waigmann H, Maniar J, Gerte S, Brede HD, Dietrich U, Mahambre G, Pfützner A. Rübsamen-Waigmann H, et al. Zentralbl Bakteriol. 1994 Jan;280(3):398-402. doi: 10.1016/s0934-8840(11)80603-1. Zentralbl Bakteriol. 1994. PMID: 8167434

7

Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigen.

Rübsamen-Waigmann H, Schröder B, Biesert L, Bauermeister CD, von Briesen H, Suhartono H, Zimmermann F, Brede HD, Regeniter A, Gerte S, et al. Rübsamen-Waigmann H, et al. Infection. 1991;19 Suppl 2:S77-82. doi: 10.1007/BF01644472. Infection. 1991. PMID: 1673119

8

Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

Dietrich U, Ruppach H, Gehring S, Knechten H, Knickmann M, Jäger H, Wolf E, Husak R, Orfanos CE, Brede HD, Rübsamen-Waigmann H, von Briesen H. Dietrich U, et al. AIDS. 1997 Oct;11(12):1532-3. AIDS. 1997. PMID: 9342084 No abstract available.

9

In vitro analysis of HIV- and non-HIV-infected monocytes/macrophages from healthy subjects and patients with malignant tumours.

Müller H, Schuster K, Krüger S, Glienke W, Rübsamen-Waigmann H, Stutte HJ. Müller H, et al. Res Virol. 1994 May-Aug;145(3-4):183-92. doi: 10.1016/s0923-2516(07)80021-5. Res Virol. 1994. PMID: 7800944

10

Distinction between HIV-1 and HIV-2 infection using novel synthetic lipopeptide conjugates as antigens in enzyme immunoassays.

Böltz T, Hummel RP, Tröger W, Rübsamen-Waigmann H, Biesert L, Müller-Lantzsch N, Koch P, Bessler W, Jung G. Böltz T, et al. J Virol Methods. 1988 Dec;22(2-3):173-82. doi: 10.1016/0166-0934(88)90100-0. J Virol Methods. 1988. PMID: 2464607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page